SCHEMBL30865166

SCHEMBL30865166

O=C(N1CC2(CC(Cc3cc(C4CC4)[nH]n3)C2)C1)N1CC2(CC(n3cnc(C(F)F)n3)C2)C1

nearest known ligand 0.57

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 6/20 0.57
▸ HCAR2 Q8TDS4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30865320 0.84 MGLL (0.53) MGLL
SCHEMBL30865406 0.83 MGLL (0.60) MGLL
SCHEMBL30865184 0.83 MGLL (0.60) MGLL
SCHEMBL30865275 0.82 MGLL (0.60) MGLL
SCHEMBL30865177 0.79 MGLL (0.51) MGLL
SCHEMBL30865229 0.78 MGLL (0.49) MGLL
SCHEMBL30865360 0.77 MGLL (0.78) MGLL
SCHEMBL30865349 0.77 MGLL (0.55) MGLL
SCHEMBL30865116 0.76 MGLL (0.50) MGLL
SCHEMBL30865228 0.75 MGLL (0.48) MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4608823-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF MONOACYLGLYCEROL LIPASE (MAGL) F. Hoffmann-La Roche AG (CH) 2025-09-03 — — EP claimed
WO-2024088922-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF MONOACYLGLYCEROL LIPASE (MAGL) F. HOFFMANN-LA ROCHE AG (CH) 2024-05-02 — — WO claimed
EP-4608823-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF MONOACYLGLYCEROL LIPASE (MAGL) F. Hoffmann-La Roche AG (CH) 2025-09-03 — — EP disclosed
WO-2024088922-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF MONOACYLGLYCEROL LIPASE (MAGL) F. HOFFMANN-LA ROCHE AG (CH) 2024-05-02 — — WO disclosed
Send feedback